Sanofi, Bristol-Myers Try To Quash Apotex Subpoenas
Calling the inquiries "irrelevant and inappropriate," Sanofi-Aventis SA and Bristol-Myers Squibb Co. have sought to snuff out six subpoenas issued by generic-drug maker Apotex Inc. in connection with settlement amount determinations...To view the full article, register now.
Already a subscriber? Click here to view full article